Sustained Release Excipients Market Size, Share & Trends Report

Sustained Release Excipients Market Size, Share & Trends Analysis Report By Route Of Administration (Oral, Transdermal), By Technology (Transdermal, Implants), By Product (Gelatin, Sugars), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: GVR-2-68038-575-5
  • Number of Pages: 120
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Market Segmentation

  • Sustained Release Excipients Market Product Outlook (Revenue, USD Million, 2018 - 2030)
    • Gelatin
    • Polymers
    • Minerals
    • Sugars
    • Alcohol
    • Chitosan
  • Sustained Release Excipients Market Technology Outlook (Revenue, USD Million; 2018 - 2030)
    • Targeted Delivery
    • Micro Encapsulation
    • Wurster Technique
    • Transdermal
    • Implants
    • Coacervation
    • Others
  • Sustained Release Excipients Market Route of Administration Outlook (Revenue, USD Million; 2018 - 2030)
    • Oral
    • Intramuscular
    • Subcutaneous
    • Transdermal
    • Vaginal
    • Ophthalmic
    • Intravenous
    • Others
  • Sustained Release Excipients Market Regional Outlook (Revenue, USD Million, 2018 - 2030)
    • North America
      • North America Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Gelatin
        • Polymers
        • Minerals
        • Sugars
        • Alcohol
        • Chitosan
      • North America Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Targeted Delivery
        • Micro Encapsulation
        • Wurster Technique
        • Transdermal
        • Implants
        • Coacervation
        • Others
      • North America Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Oral
        • Intramuscular
        • Subcutaneous
        • Transdermal
        • Vaginal
        • Ophthalmic
        • Intravenous
        • Others
      • U.S.
        • U.S. Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • U.S. Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • U.S. Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Canada
        • Canada Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Canada Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Canada Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
    • Europe
      • Europe Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Gelatin
        • Polymers
        • Minerals
        • Sugars
        • Alcohol
        • Chitosan
      • Europe Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Targeted Delivery
        • Micro Encapsulation
        • Wurster Technique
        • Transdermal
        • Implants
        • Coacervation
        • Others
      • Europe Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Oral
        • Intramuscular
        • Subcutaneous
        • Transdermal
        • Vaginal
        • Ophthalmic
        • Intravenous
        • Others
      • UK
        • UK Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • UK Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • UK Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Germany
        • Germany Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Germany Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Germany Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • France
        • France Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • France Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • France Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Spain
        • Spain Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Spain Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Spain Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Italy
        • Italy Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Italy Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Italy Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Denmark
        • Denmark Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Denmark Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Denmark Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Norway
        • Norway Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Norway Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Norway Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Sweden
        • Sweden Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Sweden Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Sweden Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
    • Asia Pacifc
      • Asia Pacifc Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Gelatin
        • Polymers
        • Minerals
        • Sugars
        • Alcohol
        • Chitosan
      • Asia Pacifc Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Targeted Delivery
        • Micro Encapsulation
        • Wurster Technique
        • Transdermal
        • Implants
        • Coacervation
        • Others
      • Asia Pacifc Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Oral
        • Intramuscular
        • Subcutaneous
        • Transdermal
        • Vaginal
        • Ophthalmic
        • Intravenous
        • Others
      • Japan
        • Japan Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Japan Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Japan Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • China
        • China Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • China Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • China Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • India
        • India Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • India Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • India Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • South Korea
        • South Korea Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • South Korea Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • South Korea Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Australia
        • Australia Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Australia Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Australia Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Thailand
        • Thailand Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Thailand Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Thailand Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
    • Latin America
      • Latin America Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Gelatin
        • Polymers
        • Minerals
        • Sugars
        • Alcohol
        • Chitosan
      • Latin America Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Targeted Delivery
        • Micro Encapsulation
        • Wurster Technique
        • Transdermal
        • Implants
        • Coacervation
        • Others
      • Latin America Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Oral
        • Intramuscular
        • Subcutaneous
        • Transdermal
        • Vaginal
        • Ophthalmic
        • Intravenous
        • Others
      • Brazil
        • Brazil Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Brazil Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Brazil Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Mexico
        • Mexico Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Mexico Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Mexico Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Argentina
        • Argentina Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Argentina Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Argentina Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
    • MEA
      • MEA Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
        • Gelatin
        • Polymers
        • Minerals
        • Sugars
        • Alcohol
        • Chitosan
      • MEA Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
        • Targeted Delivery
        • Micro Encapsulation
        • Wurster Technique
        • Transdermal
        • Implants
        • Coacervation
        • Others
      • MEA Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
        • Oral
        • Intramuscular
        • Subcutaneous
        • Transdermal
        • Vaginal
        • Ophthalmic
        • Intravenous
        • Others
      • South Africa
        • South Africa Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • South Africa Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • South Africa Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Saudi Arabia
        • Saudi Arabia Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Saudi Arabia Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Saudi Arabia Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • UAE
        • UAE Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • UAE Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • UAE Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others
      • Kuwait
        • Kuwait Sustained Release Excipients Product Outlook (Revenue, USD Million, 2018 - 2030)
          • Gelatin
          • Polymers
          • Minerals
          • Sugars
          • Alcohol
          • Chitosan
        • Kuwait Sustained Release Excipients Technology Outlook (Revenue, USD Million, 2018 - 2030)
          • Targeted Delivery
          • Micro Encapsulation
          • Wurster Technique
          • Transdermal
          • Implants
          • Coacervation
          • Others
        • Kuwait Sustained Release Excipients Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
          • Oral
          • Intramuscular
          • Subcutaneous
          • Transdermal
          • Vaginal
          • Ophthalmic
          • Intravenous
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2018 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

ISO

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon